A method of treating soil, the method comprising providing the soil with a glucosinolate- secreting plant or a source thereof and contacting said soil with a myrosinase-secreting microorganism or a source thereof.

The invention concerns a method for treating plants which involves applying the following to said plants: - at least one carbonic ester of glycerol, comprising at least one ester function formed between a group derived from carbonic acid and at least one group derived from glycerol, - at least one phytopharmaceutical substance chosen from the group formed from fungicidal substances, fungistatic substances, bactericidal substances, bacteriostatic substances, insecticidal substances, acaricidal substances, herbicidal substances, parasiticidal substances, nematicidal substances and rodenticidal substances, mole poisons, crow repellent substances, corvicidal substances, molluscicidal substances, bird and/or mammal (particularly game) repellent substances; characterised in that at least one carbonic ester of glycerol is a linear carbonic ester of glycerol, in which at least one group derived from glycerol is linked to a group derived from carbonic acid by a single ester bond, and in that at least one phytopharmaceutical substance is different from each carbonic ester of glycerol. The invention also concerns a phytopharmaceutical composition and the uses of same.

This invention relates to a system for releasing beneficial mites and the use of such a system. Mite species that can be used beneficially for human purposes may for example be employed in the control of pests, such as in the field of agriculture, including agricultural production systems for plant products, agricultural production systems for animal products, and animal husbandry, or in the field of storage of food products. The system of the invention may find use in any of these fields.

The present disclosure relates to polygalacturonan rhamnogalacturonan (PGRG1) compositions, as well as methods of making and methods of using said compositions in medicinally useful and pharmaceutically useful forms. Specifically, the present disclosure provides purified PGRG1 compositions isolated from roots of the Astragalus genus of plants, and more particularly from the species Astragalus membranaceus, as well as PGRG1 compositions having a weight average molecular weight of at least 40 kiloDaltons (kDa).

A method of increasing drought resistance of a plant, the method comprising applying a Bacillus methylotrophicus or a composition thereof (i) to the plant or to a part of the plant; and/or (ii) to an area around the plant or plant part, in an amount effective to produce an increased drought resistance in the plant as compared to the drought stress resistance of the plant in the absence of said application of Bacillus methylotrophicus or composition, is described. A biologically pure culture of a 1-aminocyclopropane-l-carboxylate (ACC) deaminase deficient Bacillus methylotrophicus bacterium strain, or a mutant thereof able to induce drought resistance in a plant are also described.

The present disclosure comprises compositions and methods for biostimulation, such as seed germination and plant growth. For example, the present disclosure comprises compositions and methods for affecting, enhancing, modulating, stimulating, or aiding plant growth. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present disclosure.

The present invention relates to a concentrated extract of algae, containing between 6 and 100% dry matter, to the production method thereof, and to the uses of same either alone or associated with another nutritional, biostimulating or phytosanitary technology, in particular to stimulate the emergence, growth, development and reproduction of plants and to prevent birds from eating seeds. The invention also relates to a method for applying the concentrated extract of algae of the invention, as well as to a seed coated with said extract.

Disclosed herein is the nucleotide sequence of the Chromobacterium subtsugae genome. Also provided are the nucleotide sequences of open reading frames in the C subtsugae genome (i.e., C. subtsugae genes). In addition, the amino acid sequences of proteins encoded by the C. subtsugae genome are provided. Nucleic acids, vectors and polypeptides comprising the aforementioned sequences are also provided. Homologues, functional fragments and conservative variants of the aforementioned sequences are also provided. Compositions having pesticidal, bioremedial and plant growth-promoting activities comprising C. subtsugae genes and proteins, and methods for the use of these compositions, are also provided.

An aqueous formulation comprising between 0.1% and 50% by weight of lipophilic composition, said formulation further comprising between 0.1% and 10% by weight of homogenising component comprising at least microcrystalline cellulose; between 0.01% and 2% by weight of clay; and the remainder in water.

The invention described herein relates to methods for treating a patient having a plurality of HLA-negative cancer cells or cancer cells with reduced HLA expression with IFN-alpha in an amount sufficient to expand and/or activate immune cells such that the activated and/or expanded immune cells kill one or more of HLA-negative cancer cells or the cancer cells with reduced HLA expression.

The present disclosure relates to biocide compositions, formulations and methods for using formulations. In particular the present disclosure relates to biocide compositions and their use in effecting biocidal activity in subterranean oil and gas wells being drilled, completed, worked over or produced.

Nematode dispersal is one of the key features for success as a biocontrol agent. Currently, commercially available nematodes do not disperse sufficiently when they are applied to a field. Since the insect target is mobile, nematodes need to be actively moving and seeking an insect host. We developed a pheromone extract from nematode growth medium that disperses nematodes. This extract was unstable in liquid form. We have found that the extract can be dried to retain activity during storage or shipment. Exposing nematodes to pheromone extract before they are applied to a field activates them to disperse and seek a new host. This exposure needs to be at least 20 min. When nematodes are actively seeking a new host this increases nematode insect encounter and increases insect mortality leading to increased effectiveness of insect nematodes as biological control agents.

Methods for accelerated cell lineage conversion and the treatment of patients with the lineage converted cells are provided. The methods include the steps of transfecting a cell with a composition that includes at least one synthetic mRNA encoding a chimeric protein that corresponds to an engineered fusion of a transcription factor and an heterologous peptide sequence derived from the C- terminal transactivation domain (TAD) of Yes-associated protein (YAP). The YAP domain enhances the epigenetic remodeling activity of the chimeric protein increasing the speed of lineage conversion. The converted cells may be used for research or administered to a human or animal patient as a therapy. The reprogramming of a somatic cell to pluripotency is accelerated by using a cocktail of mRNAs expressing a combination of reprogramming factors expressed as YAP TAD chimeras.

A biological product for the purification of water, soil, industrial wastewater from chemicals that are resistant to degradation, such as pesticides and oil, contains a composition of strains of bacteria Pseudomonas putida VKPM B-10997, Bacillus subtilis VKPM B-10999, and Rhodococcus erythropolis VKPM Ac-1882 in a weight ratio of (1-2);(1-2):1. The biological product can further contain sorbent, organic and mineral supplements, and stimulating agents. The biological product can be used for the decomposition of degradation-resistant pesticides and oil and has plant growth stimulating and fungicidal activity.

Two new Helicoverpa armigera single nucleopolyhedrovirus genotypes, HearSNPV, HearSNPV-SP1B and HearSNPV-LB6, each originating from mixtures of genotypes obtained from different locations and crops, are described. Each exhibits specific insecticidal activity against H. armigera larvae comparable to that of commonly used commercial insecticides. Further, mixing the two genotypes, especially in the ratio of 1:1, within co-occluded virions of the mixed genotypes, is capable of controlling H. armigera infestations of tomato crops and is as efficacious as commonly used chemical and biological insecticides. Their use as bioinsecticides is safe for vertebrates, in that they specifically target arthropods. In addition, they are easy to produce and good yields can be obtained by orally inoculating H. armigera larvae with HearSNPV occlusion bodies.

Compositions and methods include a new strain of Bacillus amyloliquefaciens having activity against plant pathogens. The compositions are useful for benefiting plant growth and/or conferring protection against a pathogenic infection when applied to plant foliage, flowers, fruits, bark, roots, seeds, callus tissue, grafts, cuttings, surrounding soil or growth medium, and soil or growth medium concomitant with sowing seed and planting callus tissue, grafts, and cuttings. The compositions containing the Bacillus amyloliquefaciens RTI472 strain can be applied alone or in combination with other microbial, biological, or chemical insecticides, fungicides, nematicides, bacteriocides, herbicides, plant extracts, plant growth regulators, or fertilizers. In one example, the Bacillus amyloliquefaciens RTI472 strain can be delivered to the plant as part of an integrated pest management program, with other microbial or chemical insecticides, fungicides, nematicides, bacteriocides, herbicides, plant extracts, and plant growth regulators.

The invention relates to methods, uses, systems, arrays, engineered nucleotide sequences and vectors for inhibiting bacterial population growth or for altering the relative ratio of sub-populations of first and second bacteria in a mixed population of bacteria. The invention is particularly useful, for example, for treatment of microbes such as for environmental, medical, food and beverage use. The invention relates inter alia to methods of controlling microbiologically influenced corrosion (MIC) or biofouling of a substrate or fluid in an industrial or domestic system.

An aqueous formulation comprising between 0.1% and 50% by weight of lipophilic composition, said formulation further comprising between 0.1% and 10% by weight of homogenising component comprising at least microcrystalline cellulose; between 0.01% and 2% by weight of clay; and the remainder in water.

A formulation to reduce the numbers of bacteria, particularly Gram positive bacteria, in a space such as a waste disposal bin, via the vapour phase, and active over a long period, typically several weeks. The product comprises one or more essential oils or essential oil components plus a mixture of volatile and non-volatile solvents, on a carrier such as a non-woven, sintered plastic or cardboard.

The present invention is based on the fmding that bacterial Volatile Organic Compounds (VOCs) of bacterial strains belonging to the Bacillus genus have an insect repellent activity and can accordingly be used as insect repellents. In particular the VOCs released by blends of such Bacillus strains comprising at least one Bacillus aerius strain, showed a repellent activity against insects like Anopheles gambiae s. s. and Aedes aegypti. It is accordingly an object of the present invention to provide the use of VOCs of bacterial strains belonging to the Bacillus genus as insect repellents. It further provides the use of bacterial strains belonging to the Bacillus genus as insect repellents, in particular the use of Bacillus aerius strains as insect repellents. It also provides the use of blends of bacterial strains belonging to the Bacillus genus as insect repellents, in particular blends comprising at least one Bacillus aerius strain. In a further embodiment, the present invention provides insect repellent compositions comprising blends of bacterial strains belonging to the Bacillus genus, or of the VOCs thereof.

An aqueous formulation comprising between 0.1% and 50% by weight of lipophilic composition, said formulation further comprising between 0.1% and 10% by weight of homogenising component comprising at least microcrystalline cellulose; between 0.01% and 2% by weight of clay; and the remainder in water.

The present invention includes a genetically-modified non-human animal model of longevity and increased health span, which is associated with reduced tumorigenesis and tumor metastasis, as well as related methods for increasing longevity and health span, reducing tumorigenesis and tumor metastasis, and identifying active agents that confer increased longevity or health span, or reduced tumorigenesis or tumor metastasis

This invention provides an attenuated virus comprising a modified viral genome engineered to containing multiple nucleotide substitutions that reduce the codon pair bias of a virus protein encoding sequence relative to a first host while the codon pair bias relative to a second host is not substantially reduced. In another embodiment, the invention provides an attenuated virus comprising modified viral genome engineered to containing multiple nucleotide substitutions that reduce the codon pair bias of a virus protein-encoding sequence relative to a first host and a second host. The attenuated virus may be used in a vaccine composition for inducing a protective immune response in a subject. The invention also provides a method of synthesizing the attenuated virus. Further, this invention further provides a method for preventing a subject from becoming afflicted with a virus-associated disease comprising administering to the subject a prophylactically effective dose of a vaccine composition comprising the attenuated virus.

Mutant mammalian RPE65 proteins and portions thereof, and nucleic acids encoding the mutants, for use in treating a condition related to retinal degeneration in a subject, the mutant mammalian RPE65 proteins or portions thereof having isomerohydrolase activity. A gene therapy method of treating a condition related to retinal degeneration in a mammalian subject in need of such treatment, comprising administering to the subject a therapeutically- effective amount of a vector comprising a nucleic acid encoding a mutant mammalian RPE65 protein or a portion thereof. A method of treating a condition related to retinal degeneration in a subject in need of such treatment, comprising administering to the subject a therapeutically-effective amount of at least one of a mutant mammalian RPE65 protein or a portion thereof.

La présente invention vise une composition solide rechargeable constituée d'une matrice polymérique à base de copolymères acryliques blocs et d'une substance sémiochimique volatile permettant d'obtenir l'absorption, l'adsorption, la protection et le relargage contrôlé de ladite substance sur de longues durées.